MIT researchers, together with a team from two Boston hospitals, have provided early evidence in this week’s issue of Neurology, that a simple, unobtrusive wrist sensor can measure the severity of epileptic seizures as accurately as electroencephalogra…
They say you can’t teach an old dog new tricks. Fortunately, this is not always true. Researchers at the Netherlands Institute for Neuroscience (NIN-KNAW) have now discovered how the adult brain can adapt to new situations. The Dutch researchers’ findi…
Scientists have discovered a mutation limited to brain tissue that causes hemimegalencephaly (HMG), a condition where one half of the brain is enlarged and dysfunctional, leading to intellectual disability and severe epilepsy. The research, published b…
Epilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But bra…
Epilepsy medications designed to control the disease and prevent seizures do not work effectively for approximately 25% of patients suffering from the disorder. Although surgery is the best solution for some patients, the procedure involves a craniotom…
In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approve…
New guidelines from the American Academy of Neurology will help physicians better choose seizure drugs for people on HIV/AIDS medication, avoiding deadly drug interactions and preventing critical anti-HIV drugs from becoming less effective, possibly le…
According to a large Swedish investigation published in PloS Medicine, epilepsy is not directly linked to an increased risk of committing violent crime. Although, individuals who previously experienced traumatic brain injury (TBI) have an increased ris…
Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that its neurosteroid ganaxolone which is currently under study for the treatment of partial onset seizures (POS), reported positive data in the open-label extension follow u…
A large, international team of researchers led by scientists at the University of California, San Francisco has identified the gene that causes a rare childhood neurological disorder called PKD/IC, or “paroxysmal kinesigenic dyskinesia with infantile c…
